에스토니아 - 에스토니아어 - Ravimiamet

dopharma research b.v. - florfenikool - süstelahus - 300mg 1ml 250ml 1tk; 300mg 1ml 50ml 1tk; 300mg 1ml 100ml 1tk

에스토니아 - 에스토니아어 - Ravimiamet

laboratorios hipra s.a. - florfenikool - lahus joogivees manustamiseks - 23mg 1ml 5l 1tk

에스토니아 - 에스토니아어 - Ravimiamet

interchemie werken de adelaar eesti aktsiaselts - tilmikosiin - suukaudse lahuse kontsentraat - 250mg 1ml 240ml 1tk

에스토니아 - 에스토니아어 - Ravimiamet

interchemie werken de adelaar eesti aktsiaselts - florfenikool - lahus joogivees manustamiseks - 100mg 1ml 1000ml 1tk

에스토니아 - 에스토니아어 - Ravimiamet

interchemie werken de adelaar eesti aktsiaselts - tsefkvinoom - süstesuspensioon - 25mg 1ml 100ml 1tk

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

janssen-cilag international n.v.   - paliperidoonpalmitaat - skisofreenia - psühhoeptikumid - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

에스토니아 - 에스토니아어 - Ravimiamet

interchemie werken de adelaar eesti aktsiaselts - oksütetratsükliin - pulber joogivees/piimas manustamiseks - 926,6mg 1g 100g 1tk

에스토니아 - 에스토니아어 - Ravimiamet

vetoquinol s.a. - amoksitsilliin+klavulaanhape - tablett - 600mg+150mg 10tk; 600mg+150mg 250tk; 600mg+150mg 100tk; 600mg+150mg 600tk

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - pioglitazone, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

astrazeneca ab - dapaglifloksiinpropaandioolmonohüdraat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - diabeetis kasutatavad ravimid - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. lisaks teiste ravimitega ravi 2. tüüpi diabeedi. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 ja 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.